Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.24.1.u1
Stockholders' Equity (Tables)
3 Months Ended
Feb. 29, 2024
Fair Value of Options Granted

Variables used to determine the fair value of the options granted for the three months ended February 29, 2024 and February 28, 2023 are as follows:

 

 

 

Three months ended

 

 

February 29,

 

February 28,

 

 

2024

 

2023

Weighted average values:

 

 

 

 

Expected dividends

 

0%

 

0%

Expected volatility

 

60.52%

 

55.00%

Risk free interest rate

 

3.87%

 

3.87%

Expected life

 

5 years

 

5 years

Stock Option Activity

Stock option activity for options with only service-based vesting conditions for the three months ended February 29, 2024, was as follows:

 

 

 

 

 

 

Weighted

 

 

Weighted
Average
Remaining

 

 

 

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Aggregate

 

 

 

Options

 

 

Exercise
Price

 

 

Term
(Years)

 

 

Intrinsic
Value

 

Outstanding at November 30, 2023

 

 

404,278

 

 

$

7.36

 

 

4.49

 

 

$

135,330

 

Granted

 

 

103,000

 

 

 

6.31

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Expired/forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at February 29, 2024

 

 

507,278

 

 

$

7.14

 

 

 

4.35

 

 

$

113,040

 

Exercisable at February 29, 2024

 

 

367,868

 

 

$

7.48

 

 

 

4.26

 

 

$

91,526

 

Significant Option Groups Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at February 29, 2024 and related price and contractual life information are as follows:

 

 

 

Outstanding

 

 

Exercisable

 

 

 

 

 

 

Weighted
Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Weighted

 

 

 

 

 

Weighted

 

Range of Exercise Prices

 

Outstanding

 

 

Contractual
Life
(Years)

 

 

Average
Exercise
Price

 

 

Outstanding

 

 

Average
Exercise
Price

 

$3.01 to $4.00

 

 

25,000

 

 

 

1.94

 

 

$

3.13

 

 

 

25,000

 

 

$

3.13

 

$4.01 to $5.00

 

 

123,600

 

 

 

4.35

 

 

$

4.70

 

 

 

76,015

 

 

$

4.68

 

$5.01 to $6.00

 

 

28,000

 

 

 

4.82

 

 

$

5.88

 

 

 

9,332

 

 

$

5.88

 

$6.01 to $7.00

 

 

89,433

 

 

 

5.16

 

 

$

6.48

 

 

 

39,430

 

 

$

6.48

 

$7.01 to $8.00

 

 

151,145

 

 

 

5.07

 

 

$

7.54

 

 

 

142,593

 

 

$

7.51

 

$9.01 to $10.00

 

 

29,000

 

 

 

4.01

 

 

$

9.37

 

 

 

16,233

 

 

$

9.34

 

$12.01 to $13.00

 

 

16,653

 

 

 

6.48

 

 

$

12.54

 

 

 

14,818

 

 

$

12.55

 

$13.01 to $14.00

 

 

44,447

 

 

 

0.82

 

 

$

13.50

 

 

 

44,447

 

 

$

13.50

 

 

 

507,278

 

 

 

4.35

 

 

$

7.14

 

 

 

367,868

 

 

$

7.48

 

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of February 29, 2024, and changes during the three months ended February 29, 2024, is presented below:

 

 

 

 

 

 

Weighted
Average

 

 

 

 

 

 

Grant-Date

 

 

 

Options

 

 

Fair Value

 

Non-vested at November 30, 2023

 

 

114,193

 

 

$

3.10

 

Granted

 

 

103,000

 

 

 

3.13

 

Vested

 

 

(77,783

)

 

 

3.20

 

Forfeited

 

 

 

 

 

 

Non-vested at February 29, 2024

 

 

139,410

 

 

$

3.07